Early detection of lung cancer using ultra-low-dose computed tomography in coronary CT angiography scans among patients with suspected coronary heart disease

Lung Cancer ◽  
2017 ◽  
Vol 114 ◽  
pp. 1-5 ◽  
Author(s):  
Matheus Zanon ◽  
Gabriel Sartori Pacini ◽  
Vinicius Valério Silveiro de Souza ◽  
Edson Marchiori ◽  
Gustavo Souza Portes Meirelles ◽  
...  
2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
G C Forte ◽  
R G F Andrade ◽  
L F Fiorentini ◽  
K Irion ◽  
B Hochhegger

Abstract Background Chest CT screening improves lung cancer detection at early stages for high-risk populations, such as heavy-smokers. However, CT screening also has some considerable disadvantages as radiation exposure, patient distress and overdiagnosis. Tobacco is also a major risk factor for coronary heart disease. Purpose To assess whether an additional chest ultra-low-dose CT scan to the coronary CT angiography protocol can be used for lung cancer screening among patients with suspected coronary artery disease. Methods 980 patients underwent coronary CT angiography for assessment of coronary artery disease, additionally undergoing ultra-low-dose CT screening to early diagnosis of lung cancer in the same scanner (80kVp and 15mAs). Patients presenting pulmonary nodules were followed-up for two years, repeating low-dose CTs in intervals of 3, 6, or 12 months based on nodule size and growth rate in accordance with National Comprehensive Cancer Network guidelines. Results Ultra-low-dose CT identified 437 patients with solitary pulmonary nodules (45%), with a mean diameter of 5.40±4.10mm. One hundred fifty two were >6mm, and in 83% (n=126) of these cases they were false positive findings, further confirmed by follow-up (n=114), resection (n=3), or biopsy (n=9). Lung cancer was detected in twenty nine patients due to CT screening (diagnostic yield: 2.9%). Among these, 20 cases could not be detected in the cardiac field of view. Most patients were in early stages of the disease, and eight patients diagnosed at advanced stages (IIIB and IV). The addition of the ultra-low-dose CT scan represented a radiation dose increment of 1.32±0.29% (effective dose, 0.12±0.04mSv). Conclusions Lung cancer might be detected using additional ultra-low-dose protocols in coronary CT angiography scans among patients with suspected coronary artery disease. FUNDunding Acknowledgement Type of funding sources: None.


Open Heart ◽  
2015 ◽  
Vol 2 (1) ◽  
pp. e000233 ◽  
Author(s):  
Kirsten Schou Nørgaard ◽  
Christin Isaksen ◽  
Jørgen Selmer Buhl ◽  
Jane Kirk Johansen ◽  
Agnete Hedemann Nielsen ◽  
...  

2020 ◽  
Vol 6 (2) ◽  
pp. 00131-2020
Author(s):  
Adrien Costantini ◽  
Clementine Bostantzoglou ◽  
Torsten Gerriet Blum

Lung cancer is a devastating disease affecting hundreds of thousands of patients in Europe. Despite recent advances in treatment, its prognosis remains poor. This is mainly attributed to the late stages that diagnoses are usually established at, consequently excluding curative treatment options. During the 2019 European Respiratory Society International Congress in Madrid, Spain, lung cancer experts presented the most recent aspects of lung cancer early detection with low-dose computed tomography.


2019 ◽  
Vol 65 (2) ◽  
pp. 224-233
Author(s):  
Sergey Morozov ◽  
Viktor Gombolevskiy ◽  
Anton Vladzimirskiy ◽  
Albina Laypan ◽  
Pavel Kononets ◽  
...  

Study aim. To justify selective lung cancer screening via low-dose computed tomography and evaluate its effectiveness. Materials and methods. In 2017 we have concluded the baseline stage of “Lowdose computed tomography in Moscow for lung cancer screening (LDCT-MLCS)” trial. The trial included 10 outpatient clinics with 64-detector CT units (Toshiba Aquilion 64 and Toshiba CLX). Special low-dose protocols have been developed for each unit with maximum effective dose of 1 mSv (in accordance with the requirements of paragraph 2.2.1, Sanitary Regulations 2.6.1.1192-03). The study involved 5,310 patients (53% men, 47% women) aged 18-92 years (mean age 62 years). Diagnosis verification was carried out in the specialized medical organizations via consultations, additional instrumental, laboratory as well as pathohistological studies. The results were then entered into the “National Cancer Registry”. Results. 5310 patients (53% men, 47% women) aged 18 to 92 years (an average of 62 years) participated in the LDCT-MLCS. The final cohort was comprised of 4762 (89.6%) patients. We have detected 291 (6.1%) Lung-RADS 3 lesions, 228 (4.8%) Lung- RADS 4A lesions and 196 (4.1%) Lung-RADS 4B/4X lesions. All 4B and 4X lesions were routed in accordance with the project's methodology and legislative documents. Malignant neoplasms were verified in 84 cases (1.76% of the cohort). Stage I-II lung cancer was actively detected in 40.3% of these individuals. For the first time in the Russian Federation we have calculated the number needed to screen (NNS) to identify one lung cancer (NNS=57) and to detect one Stage I lung cancer (NNS=207). Conclusions. Based on the global experience and our own practices, we argue that selective LDCT is the most systematic solution to the problem of early-stage lung cancer screening.


Sign in / Sign up

Export Citation Format

Share Document